ASX-listed Aroa Biosurgery hits over 10-week high on FY outlook

Aroa Biosurgery

22/10/2024 04:45

** ASX-listed shares of Aroa Biosurgery  ARX.AX  rise as
much as 15.4% to A$0.6, their highest since Aug. 12
    ** NZ's Medical products maker expects to be operating cash
flow positive in the second half of FY25
    ** Co says FY25 normalised EBITDA guidance maintained at
NZ$2 mln ($1.21 mln) to NZ$6 mln
    ** Says, FY25 revenue guidance maintained between NZ$80 mln
and NZ$87 mln
    ** ARX to release financial results for H1 FY25 on Nov. 26
    ** Stock down 30.7% YTD
 


($1 = 1.6543 New Zealand dollars)

 (Reporting by Ayushman Ojha in Bengaluru)
 ((Ayushman.ojha@thomsonreuters.com;))